169 related articles for article (PubMed ID: 36077630)
1. MHC Class II Expression Influences the Composition and Distribution of Immune Cells in the Metastatic Colorectal Cancer Microenvironment.
Griffith BD; Turcotte S; Lazarus J; Lima F; Bell S; Delrosario L; McGue J; Krishnan S; Oneka MD; Nathan H; Smith JJ; D'Angelica MI; Shia J; Di Magliano MP; Rao A; Frankel TL
Cancers (Basel); 2022 Aug; 14(17):. PubMed ID: 36077630
[TBL] [Abstract][Full Text] [Related]
2. Unique characteristics of the tumor immune microenvironment in young patients with metastatic colorectal cancer.
Griffith BD; Lazarus J; McGue J; Krishnan S; D'Angelica MI; Shia J; Dobrosotskaya I; Shi J; Edwards J; Rao A; Frankel TL
Front Immunol; 2023; 14():1289402. PubMed ID: 38152402
[TBL] [Abstract][Full Text] [Related]
3. Preoperative treatment with a non-steroidal anti-inflammatory drug (NSAID) increases tumor tissue infiltration of seemingly activated immune cells in colorectal cancer.
Lönnroth C; Andersson M; Arvidsson A; Nordgren S; Brevinge H; Lagerstedt K; Lundholm K
Cancer Immun; 2008 Feb; 8():5. PubMed ID: 18307280
[TBL] [Abstract][Full Text] [Related]
4. The MHC-II antigen presentation machinery and B7 checkpoint ligands display distinctive patterns correlated with acute myeloid leukaemias blast cells HLA-DR expression.
Antohe I; Tanasa MP; Dăscălescu A; Dănăilă C; Titieanu A; Zlei M; Ivanov I; Sireteanu A; Cianga P
Immunobiology; 2021 Jan; 226(1):152049. PubMed ID: 33352400
[TBL] [Abstract][Full Text] [Related]
5. Proteasome inhibitors restore the STAT1 pathway and enhance the expression of MHC class I on human colon cancer cells.
Liang YH; Chen KH; Tsai JH; Cheng YM; Lee CC; Kao CH; Chan KY; Chen YT; Hsu WL; Yeh KH
J Biomed Sci; 2021 Nov; 28(1):75. PubMed ID: 34758826
[TBL] [Abstract][Full Text] [Related]
6. Molecular characterization of major histocompatibility complex class II gene expression and demonstration of antigen-specific T cell response indicate a new phenotype in class II-deficient patients.
Hauber I; Gulle H; Wolf HM; Maris M; Eggenbauer H; Eibl MM
J Exp Med; 1995 Apr; 181(4):1411-23. PubMed ID: 7699327
[TBL] [Abstract][Full Text] [Related]
7. The absence of HLA class I expression in non-small cell lung cancer correlates with the tumor tissue structure and the pattern of T cell infiltration.
Perea F; Bernal M; Sánchez-Palencia A; Carretero J; Torres C; Bayarri C; Gómez-Morales M; Garrido F; Ruiz-Cabello F
Int J Cancer; 2017 Feb; 140(4):888-899. PubMed ID: 27785783
[TBL] [Abstract][Full Text] [Related]
8. Tumour-specific CTL response requiring interactions of four different cell types and recognition of MHC class I and class II restricted tumour antigens.
Schirrmacher V; Schild HJ; Gückel B; von Hoegen P
Immunol Cell Biol; 1993 Aug; 71 ( Pt 4)():311-26. PubMed ID: 7901150
[TBL] [Abstract][Full Text] [Related]
9. Small cell lung carcinomas express shared and private tumor antigens presented by HLA-A1 or HLA-A2.
Yamazaki K; Spruill G; Rhoderick J; Spielman J; Savaraj N; Podack ER
Cancer Res; 1999 Sep; 59(18):4642-50. PubMed ID: 10493519
[TBL] [Abstract][Full Text] [Related]
10. Loss of B7.2 (CD86) and intracellular adhesion molecule 1 (CD54) expression is associated with decreased tumor-infiltrating T lymphocytes in diffuse B-cell large-cell lymphoma.
Stopeck AT; Gessner A; Miller TP; Hersh EM; Johnson CS; Cui H; Frutiger Y; Grogan TM
Clin Cancer Res; 2000 Oct; 6(10):3904-9. PubMed ID: 11051236
[TBL] [Abstract][Full Text] [Related]
11. Human Cytomegalovirus Decreases Major Histocompatibility Complex Class II by Regulating Class II Transactivator Transcript Levels in a Myeloid Cell Line.
Sandhu PK; Buchkovich NJ
J Virol; 2020 Mar; 94(7):. PubMed ID: 31915281
[TBL] [Abstract][Full Text] [Related]
12. Spatial and phenotypic immune profiling of metastatic colon cancer.
Lazarus J; Maj T; Smith JJ; Perusina Lanfranca M; Rao A; D'Angelica MI; Delrosario L; Girgis A; Schukow C; Shia J; Kryczek I; Shi J; Wasserman I; Crawford H; Nathan H; Pasca Di Magliano M; Zou W; Frankel TL
JCI Insight; 2018 Nov; 3(22):. PubMed ID: 30429368
[TBL] [Abstract][Full Text] [Related]
13. Peritumoral administration of DRibbles-pulsed antigen-presenting cells enhances the antitumor efficacy of anti-GITR and anti-PD-1 antibodies via an antigen presenting independent mechanism.
Patel JM; Cui Z; Wen ZF; Dinh CT; Hu HM
J Immunother Cancer; 2019 Nov; 7(1):311. PubMed ID: 31747946
[TBL] [Abstract][Full Text] [Related]
14. Generation of self HLA-DR-specific CD3+CD4-CD8+ cytotoxic T cells in chronic graft-versus-host disease.
Yamamoto M; Sugihara K; Ohtsuki F; Tsujino Y; Tanaka A; Kamiya T; Wada H; Kanamaru A; Hara H; Yano A
Bone Marrow Transplant; 1994 Oct; 14(4):525-33. PubMed ID: 7858527
[TBL] [Abstract][Full Text] [Related]
15. Turning tumor cells in situ into T-helper cell-stimulating, MHC class II tumor epitope-presenters: immuno-curing and immuno-consolidation.
Hillman GG; Kallinteris NL; Lu X; Wang Y; Wright JL; Li Y; Wu S; Forman JD; Gulfo JV; Humphreys RE; Xu M
Cancer Treat Rev; 2004 May; 30(3):281-90. PubMed ID: 15059651
[TBL] [Abstract][Full Text] [Related]
16. Zwitterionic polysaccharides stimulate T cells by MHC class II-dependent interactions.
Kalka-Moll WM; Tzianabos AO; Bryant PW; Niemeyer M; Ploegh HL; Kasper DL
J Immunol; 2002 Dec; 169(11):6149-53. PubMed ID: 12444118
[TBL] [Abstract][Full Text] [Related]
17. Antigen presentation and MHC class II expression by human esophageal epithelial cells: role in eosinophilic esophagitis.
Mulder DJ; Pooni A; Mak N; Hurlbut DJ; Basta S; Justinich CJ
Am J Pathol; 2011 Feb; 178(2):744-53. PubMed ID: 21281807
[TBL] [Abstract][Full Text] [Related]
18. Composition of MHC class II-enriched lipid microdomains is modified during maturation of primary dendritic cells.
Setterblad N; Roucard C; Bocaccio C; Abastado JP; Charron D; Mooney N
J Leukoc Biol; 2003 Jul; 74(1):40-8. PubMed ID: 12832441
[TBL] [Abstract][Full Text] [Related]
19. Defining promiscuous MHC class II helper T-cell epitopes for the HER2/neu tumor antigen.
Kobayashi H; Wood M; Song Y; Appella E; Celis E
Cancer Res; 2000 Sep; 60(18):5228-36. PubMed ID: 11016652
[TBL] [Abstract][Full Text] [Related]
20. A Multi-Omics Analysis of Metastatic Melanoma Identifies a Germinal Center-Like Tumor Microenvironment in HLA-DR-Positive Tumor Areas.
Gadeyne L; Van Herck Y; Milli G; Atak ZK; Bolognesi MM; Wouters J; Marcelis L; Minia A; Pliaka V; Roznac J; Alexopoulos LG; Cattoretti G; Bechter O; Oord JVD; De Smet F; Antoranz A; Bosisio FM
Front Oncol; 2021; 11():636057. PubMed ID: 33842341
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
